PA
The startup develops a precision pacing device that enhances cardiac resynchronization therapy for heart failure patients by accurately identifying responders to specific pacemaker approaches. This technology enables healthcare professionals to select the most effective pacing strategy, improving treatment outcomes for patients with dyssynchronous heart failure.
Updated 3 months ago
Funding
$14.4M raised to dateRaised to date based on public sources. This may differ from the amount the company actually raised and is based only on what is publicly available on the internet.
Funding rounds are not available yet.
Founders
Product
Features
- The startup develops a precision pacing device that enhances cardiac resynchronization therapy for heart failure patients by accurately identifying responders to specific pacemaker approaches. This technology enables healthcare professionals to select the most effective pacing strategy, improving treatment outcomes for patients with dyssynchronous heart failure.